Enforcement of Joint Patent Rights. Scynexis and Elanco will each promptly notify the other via Notice of any alleged or threatened infringement of the Joint Patent Rights of which they become aware. Scynexis and Elanco will then confer and may agree jointly to prosecute any such infringement. If the Parties do not agree on whether or how to proceed with enforcement activity (a) within [*] following the notice of alleged infringement or (b) [*] before the time limit, if any, set forth in the appropriate laws and regulations for the filing of such actions, whichever comes first, then [*] may commence litigation with respect to the alleged or threatened infringement at its own expense. In the event that [*] does not commence litigation within [*] of the above-specified date, [*] may do so, at [*] expense. In the event a Party brings an infringement action against a Third Party, the other Party will cooperate fully, including, if required to bring such action, the furnishing of a power of attorney. (a) Except as otherwise agreed to by the Parties as part of a cost-sharing arrangement, any recovery realized as a result of such litigation (whether by way of settlement or otherwise) will be first allocated to reimbursement of unreimbursed legal fees and expenses incurred by the Party initiating the proceeding, then toward reimbursement of any unreimbursed legal fees and expenses of the other Party, and then the remainder will be divided between the Parties as follows: (y) if the award is based on lost profit], Elanco will receive an amount equal to the damages the court determines Elanco has suffered as a result of the infringement less the amount of any Royalties that would have been due to Scynexis on sales of Products lost by Elanco or any Affiliate or sublicensee of Elanco as a result of the infringement had Elanco or any Affiliate or sublicensee of Elanco made such sales, and Scynexis will receive an amount equal to the Royalties and other payments it would have received under Article V if such sales had been made by Elanco or any Affiliate or sublicensee of Elanco; and (z) as to awards other than those based on lost profits, [*] to the Party initiating such proceedings and [*] to the other Party.
Appears in 2 contracts
Samples: License, Development & Commercialization Agreement (Scynexis Inc), License, Development & Commercialization Agreement (Scynexis Inc)
Enforcement of Joint Patent Rights. Scynexis Ambrx and Elanco will each promptly notify the other via Notice in writing of any alleged or threatened infringement of the Joint Product Patent Rights of which they become aware. Scynexis Ambrx and Elanco will then confer and may agree jointly to prosecute any such infringement. If the Parties do not agree on whether or how to proceed with enforcement activity (a) within [*] ninety (90) days following the notice of alleged infringement or (b) [*] ten (10) business days before the time limit, if any, set forth in the appropriate laws and regulations for the filing of such actions, whichever comes first, then [*] (i) Elanco may commence litigation with respect to the alleged or threatened infringement at its own expenseexpense if such infringement relates solely to the Field, and (ii) Ambrx may commence litigation with respect to the alleged or threatened infringement at its own expense if such infringement relates to activities outside the Field. In the event that [*] Elanco does not commence litigation described in clause (i) of the preceding sentence within [*] five (5) business days of the above-specified date, [*] Ambrx may do so, at [*] Ambrx’ expense. In the event a Party brings an infringement action against a Third PartyParty as described herein, the other Party will cooperate fullyreasonably cooperate, including, if required to bring such action, the furnishing of a power of attorney.
(a) . Except as otherwise agreed to by the Parties as part of a cost-sharing arrangement, any recovery realized as a result of such litigation (whether by way of settlement or otherwise) with respect to a Third Party’s infringement will be first allocated to reimbursement of unreimbursed legal fees and expenses incurred by the Party initiating the proceeding, then toward reimbursement of any unreimbursed legal fees and expenses of the other Party, and then the remainder will be divided between the Parties as follows: (y) if the award is based on lost profit]profits, Elanco will receive an amount equal to the damages the court determines Elanco has suffered as a result of the infringement less the amount of any Royalties royalties that would have been due to Scynexis Ambrx on sales of Products lost by Elanco or any Affiliate or sublicensee of Elanco as a result of the infringement had Elanco or any Affiliate or sublicensee of Elanco made such sales; provided, and Scynexis will however, that Ambrx shall first receive an amount equal to the Royalties royalties and other payments it would have received under Article V if sales that would have generated such sales lost profits had been made by Elanco or any Affiliate or sublicensee of Elanco; and (z) as to awards for infringements other than those based on lost profits, [***] to the Party initiating such proceedings and [***] to the other Party.
Appears in 2 contracts
Samples: Collaborative Research, License & Commercialization Agreement (Ambrx Inc), Collaborative Research, License & Commercialization Agreement (Ambrx Inc)
Enforcement of Joint Patent Rights. Scynexis and Elanco will each If any Joint Patent is or might reasonably be infringed by a Third Party in any country in the Territory, the Party to this Agreement first having knowledge of such infringement shall promptly notify the other via Notice Party in writing. The notice shall set forth the facts of that infringement in reasonable detail. With respect to Joint Patents that are owned solely by one Party, such Party shall have the sole right, but not the ------------------------------------- /*/ Confidential Treatment Requested. obligation, to institute, prosecute, and control any alleged action or threatened infringement of the Joint Patent Rights of which they become aware. Scynexis and Elanco will then confer and may agree jointly proceeding with respect to prosecute any such infringement. The non-owning Party agrees to give the owning Party, at the owning Party's expense, including reimbursement of the non-owning Party's out-of-pocket expenses, all reasonable assistance to defend or settle any such action or proceedings. The owning Party shall bear the costs of such action or proceedings. If such suspected infringement involves a jointly-owned Joint Patent and if the Parties do not agree on whether or how to proceed with enforcement activity (a) within [*] following the notice a joint plan of alleged infringement or (b) [*] before the time limit, if any, set forth in the appropriate laws and regulations for the filing of such actions, whichever comes firstaction, then [*] may commence litigation Medeva first shall have the right, but not the obligation, to institute, prosecute, and control any action or proceeding with respect to such infringement, by counsel of its own choice and thereafter TGC shall have the alleged or threatened infringement right but not the obligation to do so. The Party not bringing the action shall have the right, at its own expense, to join as a party and be represented in any such action by counsel of its own choice. In the event that [*] does not commence litigation within [*] of the above-specified date, [*] may do so, at [*] expense. In the event a If one Party brings an infringement any such action against or proceeding with respect to a Third Partyjointly-owned Joint Patent, the other Party will cooperate fully, including, agrees to be joined as a party plaintiff if required necessary to bring such action, prosecute the furnishing action and to give the first Party reasonable assistance and authority to file and prosecute the suit. Any damages or other monetary awards recovered in an action against an infringer of a power of attorney.
(a) Except as otherwise agreed jointly-owned Joint Patent shall be applied to by the Parties as part of a cost-sharing arrangement, any recovery realized as a result of such litigation (whether by way of settlement or otherwise) will be first allocated to reimbursement of unreimbursed legal TGC and Medeva for their respective out-of-pocket expenses (including reasonable attorneys' fees and expenses) incurred in prosecuting such infringement action on a pro rata basis based upon their respective out-of- pocket expenses incurred by the Party initiating the proceeding, then toward reimbursement of any unreimbursed legal fees and until all such expenses of the other Partyhave been recovered, and then the remainder will any remaining balance shall be divided equally between the Parties as follows: (y) if the award is based on lost profit], Elanco will receive an amount equal to the damages the court determines Elanco has suffered as a result of the infringement less the amount of any Royalties that would have been due to Scynexis on sales of Products lost by Elanco or any Affiliate or sublicensee of Elanco as a result of the infringement had Elanco or any Affiliate or sublicensee of Elanco made such sales, and Scynexis will receive an amount equal to the Royalties and other payments it would have received under Article V if such sales had been made by Elanco or any Affiliate or sublicensee of Elanco; and (z) as to awards other than those based on lost profits, [*] to the Party initiating such proceedings and [*] to the other PartyParties.
Appears in 1 contract
Samples: License and Collaboration Agreement (Targeted Genetics Corp /Wa/)
Enforcement of Joint Patent Rights. Scynexis Cubist and Elanco will Novartis shall each promptly notify the other via Notice in writing of any alleged or threatened infringement of the Joint Patent Rights of which they become aware. Scynexis Cubist and Elanco will Novartis shall then confer and may agree jointly to prosecute any such infringement. If the Parties do not agree on whether or how to proceed with enforcement activity (ai) within [*] ninety (90) days following the notice of alleged infringement or (bii) [*] ten (10) business days before the time limit, if any, set forth in the appropriate laws and regulations for the filing of such actions, whichever comes first, then [*] Cubist may commence litigation with respect to the alleged or threatened infringement at its own expense, and credit against the percentage of Milestone Revenue Income and royalties otherwise due Novartis under Section 8.5 all of its expenses incurred in such action (including attorneys' fees and expenses). In the event that [*] Cubist does not commence litigation within [*] five (5) business days of the above-specified date, [*] Novartis may do so, at [*] expenseso and credit against the development milestones payments due Cubist under Section 8.3.2 and the royalties due Cubist under Section 8.4 all of its expenses incurred in such action (including attorneys' fees and expenses). In the event a Party brings an infringement action against a Third Partyaction, the other Party will shall cooperate fully, including, if required to bring such action, the furnishing of a power of attorney.
(a) . Neither Party shall have the right to settle any patent infringement litigation under this Section in a manner that diminishes the rights or interests of the other Party without the express written consent of such other Party. Except as otherwise agreed to by the Parties as part of a cost-cost sharing arrangement, any recovery realized as a result of such litigation (whether by way of settlement or otherwise) will shall be first allocated to reimbursement of unreimbursed legal fees and expenses incurred by the Party initiating the proceeding, then toward reimbursement of any unreimbursed legal fees and expenses of the other Party, then, if applicable, toward reimbursement of the other Party for the amount of any payments withheld by the Party initiating the proceeding as permitted above, and then the remainder will shall be divided between the Parties as follows: (yi) if the award is based on lost profit]profits, Elanco will Seller shall receive an amount equal to the damages the court determines Elanco the Seller has suffered as a result of the infringement less the amount of any Royalties royalties that would have been due to Scynexis the other party on sales of Products lost by Elanco or any Affiliate or sublicensee of Elanco Seller as a result of the infringement had Elanco or any Affiliate or sublicensee of Elanco Seller made such sales, and Scynexis will the other party shall receive an amount equal to the Royalties royalties and other payments it would have received under Article V 8 if such sales had been made by Elanco or any Affiliate or sublicensee of ElancoSeller; and (zii) as to awards other than those based on lost profits, [*] sixty percent (60%) to the Party party initiating such proceedings and [*] forty percent (40%) to the other Partyparty.
Appears in 1 contract
Samples: Collaborative Research and License Agreement (Cubist Pharmaceuticals Inc)
Enforcement of Joint Patent Rights. Scynexis and Elanco will each promptly notify the other via Notice of If a Party learns that any alleged or threatened infringement of the Joint Patent Rights are infringed or misappropriated by activities of which they become aware. Scynexis and Elanco will then confer and may agree jointly a Third Party relating to prosecute a Product in any such infringement. If the Parties do not agree on whether or how to proceed with enforcement activity (a) within [*] following the notice of alleged infringement or (b) [*] before the time limit, if any, set forth country in the appropriate laws and regulations for the filing of Territory, such actions, whichever comes first, then [*] may commence litigation with respect to the alleged or threatened infringement at its own expense. In the event that [*] does not commence litigation within [*] of the above-specified date, [*] may do so, at [*] expense. In the event a Party brings an infringement action against a Third Party, shall promptly notify in writing the other Party will cooperate fullyhereto. JOT shall have the initial right to enforce the Joint Patent Rights in the Territory and Aquanova agrees to join such proceeding, includingat JOT’s expense, if required by Applicable Law for JOT to bring such action. If JOT fails to initiate a suit to enforce such Joint Patent Rights relating to a Product against such a Third Party in the Territory within ninety (90) days after notification of such infringement or declines to initiate such suit, then Aquanova may initiate such suit against such infringement in the furnishing name of Aquanova and at the expense of Aquanova in the Territory; provided that JOT agrees to join such proceeding, at Aquanova’s expense, if required by Applicable Law for Aquanova to bring such action. The Party bringing any such claim, suit or proceeding (the “Enforcing Party”) pursuant to this Section 10.03, shall keep the other Party hereto reasonably informed of the progress of any such claim, suit or proceeding. Without the prior written consent of the other Party, neither Party shall enter into a power settlement with a Third Party involving such Joint Patent Rights in any manner that would negatively impact such intellectual property or that would limit or restrict the ability of attorney.
(a) Except as otherwise agreed either Party to by Commercialize the Parties as part of a costProducts anywhere in the Territory or the ROW. Aquanova and JOT shall first recover their respective actual out-sharing arrangement, of-pocket expenses associated with any litigation or settlement thereof from any recovery realized made by any Party. Any excess amount recovered shall be divided in the following manner: to JOT to cover any lost profits as a result of such litigation (whether by way of settlement infringement or otherwise) will be first allocated to reimbursement of unreimbursed legal fees and expenses incurred by the Party initiating the proceeding, then toward reimbursement of any unreimbursed legal fees and expenses of the other Partymisappropriation, and then the remainder will be divided between the Parties as follows: seventy-five percent (y75%) if the award is based on lost profit], Elanco will receive an amount equal to the damages the court determines Elanco has suffered as a result of the infringement less the amount of any Royalties that would have been due to Scynexis on sales of Products lost by Elanco or any Affiliate or sublicensee of Elanco as a result of the infringement had Elanco or any Affiliate or sublicensee of Elanco made such sales, Enforcing Party and Scynexis will receive an amount equal to the Royalties and other payments it would have received under Article V if such sales had been made by Elanco or any Affiliate or sublicensee of Elanco; and twenty-five percent (z25%) as to awards other than those based on lost profits, [*] to the Party initiating such proceedings and [*] to the other Party. JOT shall have the sole right to enforce the Joint Patent Rights in the ROW.
Appears in 1 contract
Samples: Development, Collaboration and License Agreement (Jupiter Neurosciences, Inc.)
Enforcement of Joint Patent Rights. Scynexis Lipid Sciences and Elanco will each promptly notify the other via Notice in writing of any alleged or threatened infringement of the Joint Patent Rights of which they become aware. Scynexis Lipid Sciences and Elanco will then confer and may agree jointly to prosecute any such infringement. If the Parties do not agree on whether or how to proceed with enforcement activity (a) within [*] ninety (90) days following the notice of alleged infringement or (b) [*] ten (10) business days before the time limit, if any, set forth in the appropriate laws and regulations for the filing of such actions, whichever comes first, then [*] Elanco may commence litigation with respect to the alleged or threatened infringement at its own expense. In the event that [*] Elanco does not commence litigation within [*] five (5) business days of the above-specified date, [*] Lipid Sciences may do so, at [*] Lipid Sciences’ expense. In the event a Party brings an infringement action against a Third Party, the other Party will cooperate fully, including, if required provided that there is a mutual agreement as to bring such the purpose and goal of the enforcement action, the furnishing of a power of attorney.
(a) . Except as otherwise agreed to by the Parties as part of a cost-sharing arrangement, any recovery realized as a result of such litigation (whether by way of settlement or otherwise) will be first allocated to reimbursement of unreimbursed legal fees and expenses incurred by the Party initiating the proceeding, then toward reimbursement of any unreimbursed legal fees and expenses of the other Party, and then the remainder will be divided between the Parties as follows: (y) if the award is based on lost profit]profits, Elanco will receive an amount equal to the damages the court determines Elanco has suffered as a result of the infringement less the amount of any Royalties royalties that would have been due to Scynexis Lipid Sciences on sales of Products Product(s) and/or New Product(s) lost by Elanco or any Affiliate or sublicensee of Elanco as a result of the infringement had Elanco or any Affiliate or sublicensee of Elanco made such sales, and Scynexis Lipid Sciences will receive an amount equal to the Royalties royalties and other payments it would have received under Article V VI if such sales had been made by Elanco or any Affiliate or sublicensee of Elanco; and (z) as to awards other than those based on lost profits, [*] sixty percent (60%) to the Party initiating such proceedings and [*] forty percent (40%) to the other Party.
Appears in 1 contract
Samples: Collaborative Research & License Agreement (Lipid Sciences Inc/)
Enforcement of Joint Patent Rights. Scynexis and Elanco will each If any JOINT PATENT is infringed by a THIRD PARTY in any country in the TERRITORY, the Party to this Agreement first having knowledge of such infringement shall promptly notify the other via Notice of any alleged or threatened infringement of the Joint Patent Rights of which they become awarein writing. Scynexis and Elanco will then confer and may agree jointly to prosecute any such infringement. If the Parties do not agree on whether or how to proceed with enforcement activity (a) within [*] following the The notice of alleged infringement or (b) [*] before the time limit, if any, shall set forth the facts of that infringement in reasonable detail. Aradigm shall have the appropriate laws primary right, but not the obligation, to institute, prosecute, and regulations for the filing of such actions, whichever comes first, then [*] may commence litigation control any action or proceeding with respect to such infringement, by counsel of its own choice, and SB shall have the alleged right, at its own expense, to be represented in any such action by counsel of its own choice. If Aradigm fails to bring an action or threatened infringement proceeding against such suspected infringer within a period of ninety (90) days after having knowledge of such infringement, then SB shall have the right to bring and control an action against such infringer by counsel of its own choice, and Aradigm shall have the right to be represented in any such action by counsel of its own choice at its own expense. In The Party controlling any such action shall consider in good faith the event that [*] does not commence litigation within [*] interests of the above-specified date, [*] may do so, at [*] expense. In the event a Party brings an infringement action against a Third Party, the other Party will cooperate fullyin so doing, including, if required and shall not settle or consent to bring an adverse judgment in any such action, action which would have a material adverse effect on the furnishing rights or interests of a power of attorney.
(a) Except as otherwise agreed to by the Parties as part of a cost-sharing arrangement, any recovery realized as a result of such litigation (whether by way of settlement or otherwise) will be first allocated to reimbursement of unreimbursed legal fees and expenses incurred by other Party without the Party initiating the proceeding, then toward reimbursement of any unreimbursed legal fees and expenses prior express written consent of the other Party, which consent shall not be unreasonably withheld. If one Party brings any such action or proceeding with respect to a JOINT PATENT, the other Party agrees to be joined as a Party plaintiff if necessary to prosecute the action and then to give the remainder will first Party reasonable assistance and authority to file and prosecute the suit. Any damages or other monetary awards recovered in an action against an infringer of a JOINT PATENT shall be divided between allocated to the Parties as followsin the following manner: (y) if the award is based on lost profit]first, Elanco will receive an amount equal to the damages reimbursement of Aradigm and SB * Certain information on this page has been omitted and filed separately with the court determines Elanco Commission. Confidential treatment has suffered as a result of the infringement less the amount of any Royalties that would have been due to Scynexis on sales of Products lost by Elanco or any Affiliate or sublicensee of Elanco as a result of the infringement had Elanco or any Affiliate or sublicensee of Elanco made such sales, and Scynexis will receive an amount equal requested with respect to the Royalties and other payments it would have received under Article V if such sales had been made by Elanco or any Affiliate or sublicensee of Elanco; and (z) as to awards other than those based on lost profits, [*] to the Party initiating such proceedings and [*] to the other Partyomitted portions.
Appears in 1 contract
Samples: Product Development and Commercialization Agreement (Aradigm Corp)
Enforcement of Joint Patent Rights. Scynexis and Elanco will each If any Joint Patent is infringed by a Third Party in any country in the Territory, the Party to this Agreement first having knowledge of such infringement shall promptly notify the other via Notice in writing. The notice shall set forth the facts of that infringement in reasonable detail. With respect to Joint Patents that are owned solely by one Party, such Party shall have the sole right, but not the obligation, to institute, prosecute, and control any alleged action or threatened infringement of the Joint Patent Rights of which they become aware. Scynexis and Elanco will then confer and may agree jointly proceeding with respect to prosecute any such infringement. If the Parties do not agree on whether or how to proceed with enforcement activity (a) within [*] following the notice of alleged such suspected infringement or (b) [*] before the time limit, if any, set forth in the appropriate laws and regulations for the filing of such actions, whichever comes firstinvolves a jointly owned Joint Patent, then [*] may commence litigation Lynx shall have the primary right, but not the obligation, to institute, prosecute, and control any action or proceeding with respect to such infringement, by counsel of its own choice, and Xxxxxxx Pharma shall have the alleged right, at its own expense, to be represented in any such action by counsel of its own choice. If the suspected infringement of a Joint Patent involves an Infringement in the Field, and Lynx fails to bring an action or threatened infringement proceeding against such suspected infringer within a period of [REDACTED] days after having knowledge of such Infringement in the Field, then Xxxxxxx Pharma shall have the right to bring and control an action against such infringer by counsel of its own choice, and Lynx shall have the right to be represented in any such action by counsel of its own choice at its own expense. In The Party controlling any such action involving an CONFIDENTIAL TREATMENT REQUESTED 38. Infringement in the event that [*] does not commence litigation within [*] Field shall consider in good faith the interests of the above-specified dateother Party in so doing, [*] may do so, at [*] expenseand shall not settle or consent to an adverse judgment in any such action which would have a material adverse effect on the rights or interests of the other Party without the prior express written consent of the other Party. In the event a If one Party brings an infringement any such action against or proceeding with respect to a Third Partyjointly-owned Joint Patent, the other Party will cooperate fullyagrees to be joined as a Party plaintiff if necessary to prosecute the action and to give the first Party reasonable assistance and authority to file and prosecute the suit. Any damages or other monetary awards recovered in an action against an infringer of a jointly-owned Joint Patent based on an Infringement in the Field shall be allocated to the Parties in the following manner: first, including, if required to bring the reimbursement of Lynx and Xxxxxxx Pharma for their respective out-of-pocket expenses (including reasonable attorneys' fees and costs) incurred in prosecuting such infringement action, the furnishing of on a power of attorney.
(a) Except as otherwise agreed to by the Parties as part of a costpro rata basis based upon their respective out-sharing arrangement, any recovery realized as a result of such litigation (whether by way of settlement or otherwise) will be first allocated to reimbursement of unreimbursed legal fees and expenses incurred by the Party initiating the proceeding, then toward reimbursement of any unreimbursed legal fees and expenses of the other Party, and then the remainder will be divided between the Parties as follows: (y) if the award is based on lost profit], Elanco will receive an amount equal to the damages the court determines Elanco has suffered as a result of the infringement less the amount of any Royalties that would have been due to Scynexis on sales of Products lost by Elanco or any Affiliate or sublicensee of Elanco as a result of the infringement had Elanco or any Affiliate or sublicensee of Elanco made such sales, and Scynexis will receive an amount equal to the Royalties and other payments it would have received under Article V if such sales had been made by Elanco or any Affiliate or sublicensee of Elancoof-pocket expenses; and (z) as second, the balance to awards other than those based on lost profits, be allocated [*REDACTED] to the Party initiating such proceedings bringing suit and [*REDACTED] to the other Party.
Appears in 1 contract